Catalyst Brief

← Calendar

Readoutin 104d

Suzhou Suncadia Biopharmaceuticals Co., Ltd. — SHR-A1912 Injection

Phase 3 primary completion: A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma.

Date
Mar 2027
Type
Readout
Indication
Diffuse Large B-cell Lymphoma

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Suzhou Suncadia Biopharmaceuticals Co., Ltd.

  1. Dec2026